Daptacel DTaP
Selected indexed studies
- Quadracel: Vaccination Against Diphtheria, Tetanus, Pertussis, and Poliomyelitis in Children. (P T, 2016) [PMID:27069343]
- Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose. (MMWR Morb Mortal Wkly Rep, 2015) [PMID:26334944]
- Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system. (Front Cell Infect Microbiol, 2026) [PMID:41704959]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Quadracel: Vaccination Against Diphtheria, Tetanus, Pertussis, and Poliomyelitis in Children. (2016) pubmed
- Licensure of a Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine and Guidance for Use as a Booster Dose. (2015) pubmed
- Diphtheria-tetanus-acellular pertussis vaccine safety in children under 7 years: a post-marketing analysis of the U.S. vaccine adverse event reporting system. (2026) pubmed
- Safety and immunogenicity of a pentavalent vaccine compared with separate administration of licensed equivalent vaccines in US infants and toddlers and persistence of antibodies before a preschool booster dose: a randomized, clinical trial. (2009) pubmed
- Food and Drug Administration approval of a fifth acellular pertussis vaccine for use among infants and young children--United States, 2002. (2002) pubmed